The event is built around 1-2-1 meetings that connect global pharma BD & Licensing professionals together, empowered further by the content-driven programme. Whether you join us to understand where the generics industry is heading, to learn about BD opportunities in #pharmerging and #mature markets or to arrange for the #partnering_meetings with new and established BD peers – #PharmaSynergy is your go-to event for #Business_Development & Licensing.
This PharmaSynergy Autumn edition is focused on generics / primary care & OTC.
Product portfolio focus: Generics, niche, branded and OTC, CHC
- Considering the short- and long-term impacts on the pharmaceutical market and licensing environment. What are therapeutic categories in prescription branded and generic products showing the most growth potential? What effect does the current environment have on non-covid products' performance?
- Primary products and OTC: innovative commercialization approaches and Go-to-Market strategies
- Spotlight: Exploring medical cannabis market landscape and opportunities
- Spotlight: Digital therapeutics (DTx): operational and commercial practicalities
What to expect from 1-2-1 partnering?
Building upon the success of five consecutive editions (live & virtual), #PharmaSynergy is a global partnering event for dynamic pharma with value-added/niche generics & OTC portfolios. The event offers an intensive content-driven programme and pre-arranged partnering meetings.
With 15% of CEOs / Managing Directors, 47% of Senior Vice Presidents / Heads of Business Development, and 38% of BD Managers your conversations convert into business opportunities.
A broad-spectrum of product portfolios for both In & Out-Licensing conversations. Whether it is “live or digital”, a carefully composed profile-matching mechanism based on key sector-driven criteria allows for efficient and targeted partnering meetings.
A truly international B2B platform: the event offers a partnering opportunity with key players from Europe, Africa, LATAM, CIS, SEA and MENA.
What do our attendees think about PharmaSynergy?
‘Very good overview of the Emerging Markets’
International Marketing and Business Development Manager, Protina Pharmazeutische GMBH (Germany)
This PharmaSynergy edition was exceptional, I have just finished my scheduled meetings, and have lots of excellent leads, creative ideas and relations with wonderful industry colleagues, more than I have expected and had in previous editions.
– SAJA Pharmaceuticals (Saudi Arabia)
'The organization was perfect and enabled participants to enhance their knowledge as well as create the opportunity to have pre-scheduled B2B meetings.’
International Markets Director, Abdi Ibrahim Pharmaceuticals (Turkey)
It was a great event, congratulations! There were fantastic companies attending and very interesting speakers.
– Reig Jofre (Spain)
‘Very good content preparation’
General Manager of China Medical System Holdings (China)